Harmony Biosciences Holdings
HRMY69
$39.05arrow_drop_up1.24%$0.48
HRMY69
$39.05
arrow_drop_up1.24%| Key Stats | |
|---|---|
| Open | $38.65 |
| Prev. Close | $38.54 |
| EPS | 2.14 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 38.46 | 39.63 |
| 52 Week Range | 18.61 | 41.57 |
| Ratios | |
|---|---|
| EPS | 2.14 |
| Fundamentals | |
|---|---|
| Payout Ratio | - |
| Industry average yield | 2.87% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
HRMY-
US Healthcare Sector-
US Market-
warning
HRMY / Market
HRMY lose to the US Market which returned 1.31% over the last twenty four hours.warning
HRMY / Healthcare Sector
HRMY lose to the US Healthcare sector which returned 2.66% over the last twenty four hours.Harmony Biosciences Holdings (HRMY) Statistics
Keep an eye on Harmony Biosciences Holdings
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How much debt does Harmony Biosciences Holdings (HRMY) have?
Harmony Biosciences Holdings (HRMY) has a total debt of $185.24M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$204.52M.
help
What is the EBITDA of Harmony Biosciences Holdings (HRMY) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Harmony Biosciences Holdings (HRMY) is $228.32M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How has Harmony Biosciences Holdings (HRMY) stock's performance compared to its sector and the market over the past year?
Over the past year, Harmony Biosciences Holdings (HRMY) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 27.09%, Harmony Biosciences Holdings has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 48.15%, it has fallen short of the market average. This comparison highlights Harmony Biosciences Holdings's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Harmony Biosciences Holdings (HRMY) stock?
The PE (Price to Earnings) ratio of Harmony Biosciences Holdings (HRMY) is currently 18.25. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help
What is the EPS of Harmony Biosciences Holdings (HRMY) stock?
The Earnings Per Share (EPS) for Harmony Biosciences Holdings (HRMY), calculated on a diluted basis, is $2.14. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Harmony Biosciences Holdings (HRMY) stock?
The operating margin for Harmony Biosciences Holdings (HRMY) is 33.17%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.